Patents by Inventor Gilles Amouyal

Gilles Amouyal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240238372
    Abstract: The present invention relates to the use of the HIP/PAP protein, or a derivative thereof, for treating or preventing peripheral neuropathy in a individual, in particular diabetic peripheral neuropathy in a diabetic or prediabetic individual. It also relates to the use of the HIP/PAP protein, or a derivative thereof, for preventing a complication of peripheral neuropathy in a individual, and in particular for preventing a diabetic foot wound, in particular a diabetic foot ulcer, and its consequences.
    Type: Application
    Filed: May 6, 2022
    Publication date: July 18, 2024
    Inventors: Christian BRÉCHOT, Gilles AMOUYAL, Paul AMOUYAL, Lyse SANTORO, Fanny ROTH, Laure JAMOT
  • Patent number: 9629896
    Abstract: The invention relates to a HIP/PAP protein or to one of the derivatives thereof for use thereof for treating or preventing insulin resistance in non-insulin dependent subjects.
    Type: Grant
    Filed: April 4, 2014
    Date of Patent: April 25, 2017
    Assignees: ALFACT INNOVATION, INSERM (INSTITUTE NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE PARIS SUD, UNIVERSITE PARIS DIDEROT—PARIS 7
    Inventors: Fabrizio Andreelli, Paul Amouyal, Christophe Magnan, Celine Cruciani-Guglielmacci, Jamila Vaivre, Marion Darnaud, Laure Jamot, Christian Brechot, Gilles Amouyal
  • Patent number: 9474783
    Abstract: This invention concerns a HIP/PAP protein or derivative thereof, for its use in treating or managing cancer and preferentially solid tumors.
    Type: Grant
    Filed: July 18, 2013
    Date of Patent: October 25, 2016
    Assignees: ALFACT INNOVATION, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE PARIS SUD
    Inventors: Jamila Faivre, Eric Vibert, Marion Darnaud, Laure Jamot, Christian Brechot, Paul Amouyal, Gilles Amouyal
  • Publication number: 20160058833
    Abstract: The invention relates to a HIP/PAP protein or to one of the derivatives thereof for use thereof for treating or preventing insulin resistance in non-insulin dependent subjects.
    Type: Application
    Filed: April 4, 2014
    Publication date: March 3, 2016
    Inventors: Fabrizio Andreelli, Paul Amouyal, Christophe Magnan, Celine Cruciani-Guglielmacci, Jamila Vaivre, Marion Darnaud, Laure Jamot, Christian Brechot, Gilles Amouyal
  • Publication number: 20150190465
    Abstract: This invention concerns a HIP/PAP protein or derivative thereof, for its use in treating or managing cancer and preferentially solid tumors.
    Type: Application
    Filed: July 18, 2013
    Publication date: July 9, 2015
    Inventors: Jamila Faivre, Eric Vibert, Marion Darnaud, Laure Jamot, Christian Brechot, Paul Amouyal, Gilles Amouyal
  • Publication number: 20120142604
    Abstract: The use of the HIP/PAP protein or a protein derivative thereof for manufacturing a medicament for preventing or treating: a neonatal brain injury, which includes a neonatal brain injury caused by a brain hypoxia, an adult or child brain injury, which includes an adult or child brain injury caused by a brain hypoxia, an adult or child or neonatal traumatic brain injury, a cerebellar disease or disorder, and a disease involving a defect in the production or in the phosphorylation of Gap-43.
    Type: Application
    Filed: June 11, 2010
    Publication date: June 7, 2012
    Applicant: ALFACT INNOVATION
    Inventors: Jamila Faivre, Pierre Gressens, Gilles Amouyal, Paul Amouyal, Christian Brechot, Elodie Rougier